Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
AxiomX Inc Next-generation antibody development platform. |
United States | 1 Nov 2015 | Acquisition Led the investment round. Active |
|
|
Epitomics Inc |
United States | 5 Mar 2012 | Acquisition USD 170,000,000 (USD 170,000,000) deal size. Active |